Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.7 HKD | 0.00% | +5.19% | -15.60% |
04-25 | Simcere Pharmaceutical’ Profit Down 23% in 2023 | MT |
04-10 | Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.60% | 1.87B | |
+20.09% | 43.95B | |
+22.22% | 22.49B | |
+13.60% | 14.71B | |
+10.60% | 13.77B | |
+41.29% | 12.3B | |
-8.70% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.75% | 5.48B |
- Stock Market
- Equities
- 2096 Stock
- News Simcere Pharmaceutical Group Limited
- Simcere Pharmaceutical : Pharma Wins Clinical Trial Approval in China for New Use of Chemotherapy Medicine